People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

RELATED: Gynecologist Cautions Women About This "Overlooked" Ozempic Side Effect. Scientists found that Ozempic can weaken ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

Learn more about Ozempic, including dosing, side effects, and administration. Ozempic is only FDA approved for people with type 2 diabetes. However, doctors sometimes prescribe it off-label for ...

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...

While researchers are still studying the effects of Wegovy in the body, it’s thought that Wegovy targets areas ... and Ozempic both contain semaglutide, but Wegovy provides a higher dose.

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...